NantHealth Inc. (NH)
NASDAQ: NH
· Real-Time Price · USD
1.35
0.00 (0.00%)
At close: Jan 16, 2025, 10:00 PM
NantHealth Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 12.47M | 17.25M | 17.05M | 17.5M | 16.63M | 16.5M | 16.37M | 16.03M | 14.31M | 16.09M | 16.17M |
Cost of Revenue | 5.41M | 5.71M | 6.42M | 7.38M | 6.93M | 7.35M | 7.18M | 6.93M | 6.78M | 7.01M | 7.04M |
Gross Profit | 7.06M | 11.55M | 10.63M | 10.11M | 9.7M | 9.15M | 9.19M | 9.1M | 7.53M | 9.08M | 9.13M |
Operating Income | -10.51M | -8.73M | -12.23M | -12.97M | -14.16M | -11.71M | -12.49M | -11.86M | -11.07M | -8.59M | -9.37M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -14.93M | -17.58M | -12.17M | -25.96M | -13.67M | -12.54M | -15.93M | -16.63M | -10.88M | -15.44M | -15.51M |
Net Income | -14.99M | -17.48M | -12.24M | -25.66M | -13.66M | -12.51M | -15.95M | -16.7M | -10.84M | -15.3M | -15.41M |
Selling & General & Admin | 8.72M | 12.63M | 16.7M | 16.92M | 16.58M | 14.02M | 14.98M | 14.78M | 12.97M | 11.84M | 12.5M |
Research & Development | 2.36M | 6.66M | 5.16M | 5.17M | 6.3M | 5.86M | 5.71M | 5.2M | 4.65M | 4.85M | 5.01M |
Other Expenses | 1.08M | n/a | 985K | 986K | 985K | 2.64M | 6K | -1.23M | 3.76M | -3.05M | -2.57M |
Operating Expenses | 12.16M | 19.29M | 22.85M | 23.08M | 23.86M | 20.86M | 21.68M | 20.97M | 18.6M | 17.67M | 18.5M |
Interest Expense | -4.87M | -4.8M | 4.15M | 3.69M | 3.51M | 3.47M | 3.45M | 3.54M | 3.57M | 3.8M | 3.57M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 17.57M | 25M | 29.28M | 30.47M | 30.79M | 28.21M | 28.86M | 27.89M | 25.38M | 24.68M | 25.54M |
Income Tax Expense | 54K | -94K | 74K | -298K | -10K | -29K | 20K | 76K | 23K | 6K | -8K |
Shares Outstanding (Basic) | 7.7M | 7.7M | 7.7M | 7.7M | 7.7M | 7.7M | 7.7M | 7.7M | 7.68M | 7.63M | 7.42M |
Shares Outstanding (Diluted) | 7.7M | 7.7M | 7.7M | 7.7M | 7.7M | 7.7M | 7.7M | 7.7M | 7.68M | 7.63M | 7.42M |
EPS (Basic) | -1.95 | -2.27 | -1.59 | -3.33 | -1.77 | -1.62 | -2.07 | -2.17 | -1.41 | -2 | -2.08 |
EPS (Diluted) | -1.95 | -2.27 | -1.59 | -3.33 | -1.77 | -1.62 | -2.07 | -2.17 | -1.41 | -2 | -2.08 |
EBITDA | -10.51M | -8.73M | -5.07M | -18.19M | -6.14M | -5.19M | -8.47M | -12.1M | -11.07M | -8.59M | -9.37M |
EBIT | -19.8M | -22.38M | -8.01M | -22.27M | -10.16M | -9.07M | -12.48M | -13.09M | -7.31M | -11.64M | -11.94M |
Depreciation & Amortization | -39.59K | 122.08K | 7.16M | -5.22M | 8.02M | 3.88M | 4.01M | 987K | 3.9M | 3.9M | 3.8M |